1-(4-Methoxyphenyl)cyclopentanecarbonitrile - CAS 1206-15-1
Catalog: |
BB004920 |
Product Name: |
1-(4-Methoxyphenyl)cyclopentanecarbonitrile |
CAS: |
1206-15-1 |
Synonyms: |
1-(4-methoxyphenyl)-1-cyclopentanecarbonitrile; 1-(4-methoxyphenyl)cyclopentane-1-carbonitrile |
IUPAC Name: | 1-(4-methoxyphenyl)cyclopentane-1-carbonitrile |
Description: | 1-(4-Methoxyphenyl)cyclopentanecarbonitrile (CAS# 1206-15-1) is a useful research chemical. |
Molecular Weight: | 201.26 |
Molecular Formula: | C13H15NO |
Canonical SMILES: | COC1=CC=C(C=C1)C2(CCCC2)C#N |
InChI: | InChI=1S/C13H15NO/c1-15-12-6-4-11(5-7-12)13(10-14)8-2-3-9-13/h4-7H,2-3,8-9H2,1H3 |
InChI Key: | DOZAMVFROCVJLO-UHFFFAOYSA-N |
Boiling Point: | 135-139 °C (3 mmHg) |
Density: | 1.0862 g/cm3 |
LogP: | 3.03058 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
KR-101772134-B1 | N2-(2-methoxyphenyl)pyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient | 20150414 |
KR-20160123231-A | N2-(2-methoxyphenyl)pyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient | 20150414 |
US-10100019-B2 | N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient | 20150414 |
US-2018111905-A1 | N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient | 20150414 |
WO-2016167511-A2 | N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient | 20150414 |
Complexity: | 251 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 201.115364102 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 201.115364102 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 33 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS